Nanovehicles for co-delivery of anticancer agents

Mahdi Zeinali; Soheil Abbaspour-Ravasjani; Marjan Ghorbani; Afshin Babazadeh; Tannaz Soltanfam; Ana Cláudia Santos; Hamed Hamishehkar; Michael R. Hamblin

doi:10.1016/j.drudis.2020.06.027

Nanovehicles for co-delivery of anticancer agents

Mahdi Zeinali, Soheil Abbaspour-Ravasjani, Marjan Ghorbani, Afshin Babazadeh, Tannaz Soltanfam, Ana Cláudia Santos, Hamed Hamishehkar, Michael R. Hamblin

Laser Research Centre

Research output: Contribution to journal › Review article › peer-review

76 Citations (Scopus)

Abstract

Using nanovehicles for co-delivery of two or more anticancer agents shows benefits including: synergistic effects, promoting apoptosis pathways, reduction of toxicity and side effects, and overcoming multidrug resistance.

Original language	English
Pages (from-to)	1416-1430
Number of pages	15
Journal	Drug Discovery Today
Volume	25
Issue number	8
DOIs	https://doi.org/10.1016/j.drudis.2020.06.027
Publication status	Published - Aug 2020

ASJC Scopus subject areas

Pharmacology
Drug Discovery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.drudis.2020.06.027

Cite this

@article{4db8edd5f6f74f26a9a76ace9f218e23,

title = "Nanovehicles for co-delivery of anticancer agents",

abstract = "Using nanovehicles for co-delivery of two or more anticancer agents shows benefits including: synergistic effects, promoting apoptosis pathways, reduction of toxicity and side effects, and overcoming multidrug resistance.",

author = "Mahdi Zeinali and Soheil Abbaspour-Ravasjani and Marjan Ghorbani and Afshin Babazadeh and Tannaz Soltanfam and Santos, {Ana Cl{\'a}udia} and Hamed Hamishehkar and Hamblin, {Michael R.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",

year = "2020",

month = aug,

doi = "10.1016/j.drudis.2020.06.027",

language = "English",

volume = "25",

pages = "1416--1430",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - Nanovehicles for co-delivery of anticancer agents

AU - Zeinali, Mahdi

AU - Abbaspour-Ravasjani, Soheil

AU - Ghorbani, Marjan

AU - Babazadeh, Afshin

AU - Soltanfam, Tannaz

AU - Santos, Ana Cláudia

AU - Hamishehkar, Hamed

AU - Hamblin, Michael R.

PY - 2020/8

Y1 - 2020/8

N2 - Using nanovehicles for co-delivery of two or more anticancer agents shows benefits including: synergistic effects, promoting apoptosis pathways, reduction of toxicity and side effects, and overcoming multidrug resistance.

AB - Using nanovehicles for co-delivery of two or more anticancer agents shows benefits including: synergistic effects, promoting apoptosis pathways, reduction of toxicity and side effects, and overcoming multidrug resistance.

UR - http://www.scopus.com/inward/record.url?scp=85087987422&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2020.06.027

DO - 10.1016/j.drudis.2020.06.027

M3 - Review article

C2 - 32622880

AN - SCOPUS:85087987422

SN - 1359-6446

VL - 25

SP - 1416

EP - 1430

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 8

ER -

Nanovehicles for co-delivery of anticancer agents

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this